Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation

Mucopolysaccharidosis type II is a disease caused by organ accumulation of glycosaminoglycans due to iduronate 2-sulfatase deficiency. This study investigated the pathophysiology of the bone complications associated with mucopolysaccharidosis II and the effect of lentivirus-mediated gene therapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Miho, Shimada, Yohta, Iizuka, Sayoko, Ishii, Natsumi, Hiraki, Hiromi, Tachibana, Toshiaki, Maeda, Kazuhiro, Saito, Mitsuru, Arakawa, Shoutaro, Ishimoto, Takuya, Nakano, Takayoshi, Ida, Hiroyuki, Ohashi, Toya, Kobayashi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567932/
https://www.ncbi.nlm.nih.gov/pubmed/33102618
http://dx.doi.org/10.1016/j.omtm.2020.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567932/
https://www.ncbi.nlm.nih.gov/pubmed/33102618
http://dx.doi.org/10.1016/j.omtm.2020.09.012

Ejemplares similares